Nutrien (NTR) Competitors

Nutrien has higher revenue and earnings than Intrepid Potash. Nutrien is trading at a lower price-to-earnings ratio than Intrepid Potash, indicating that it is currently the more affordable of the two stocks.

Nutrien has a beta of 0.62, indicating that its stock price is 38% less volatile than the broader market. Comparatively, Intrepid Potash has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market.

63.1% of Nutrien shares are held by institutional investors. Comparatively, 56.1% of Intrepid Potash shares are held by institutional investors. 3.1% of Nutrien shares are held by company insiders. Comparatively, 2.3% of Intrepid Potash shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Nutrien presently has a consensus price target of $81.15, suggesting a potential upside of 13.99%. Intrepid Potash has a consensus price target of $29.00, suggesting a potential downside of 10.22%. Given Nutrien's higher possible upside, equities research analysts plainly believe Nutrien is more favorable than Intrepid Potash.

In the previous week, Nutrien had 7 more articles in the media than Intrepid Potash. MarketBeat recorded 7 mentions for Nutrien and 0 mentions for Intrepid Potash. Nutrien's average media sentiment score of 0.82 beat Intrepid Potash's score of 0.00 indicating that Nutrien is being referred to more favorably in the media.

Intrepid Potash has a net margin of 8.94% compared to Nutrien's net margin of 8.44%. Nutrien's return on equity of 8.88% beat Intrepid Potash's return on equity.

Mosaic has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market. Comparatively, Nutrien has a beta of 0.62, indicating that its stock price is 38% less volatile than the broader market.

Mosaic pays an annual dividend of $0.88 per share and has a dividend yield of 3.9%. Nutrien pays an annual dividend of $2.20 per share and has a dividend yield of 3.1%. Mosaic pays out -43.6% of its earnings in the form of a dividend. Nutrien pays out 44.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Mosaic has increased its dividend for 7 consecutive years and Nutrien has increased its dividend for 7 consecutive years. Mosaic is clearly the better dividend stock, given its higher yield and lower payout ratio.

Nutrien has higher revenue and earnings than Mosaic. Mosaic is trading at a lower price-to-earnings ratio than Nutrien, indicating that it is currently the more affordable of the two stocks.

In the previous week, Nutrien had 5 more articles in the media than Mosaic. MarketBeat recorded 7 mentions for Nutrien and 2 mentions for Mosaic. Mosaic's average media sentiment score of 0.86 beat Nutrien's score of 0.82 indicating that Mosaic is being referred to more favorably in the media.

Nutrien has a net margin of 8.44% compared to Mosaic's net margin of -5.21%. Nutrien's return on equity of 8.88% beat Mosaic's return on equity.

77.5% of Mosaic shares are held by institutional investors. Comparatively, 63.1% of Nutrien shares are held by institutional investors. 0.3% of Mosaic shares are held by company insiders. Comparatively, 3.1% of Nutrien shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Mosaic presently has a consensus target price of $27.17, suggesting a potential upside of 21.46%. Nutrien has a consensus target price of $81.15, suggesting a potential upside of 13.99%. Given Mosaic's higher probable upside, analysts clearly believe Mosaic is more favorable than Nutrien.

Nutrien has higher revenue and earnings than Corteva. Nutrien is trading at a lower price-to-earnings ratio than Corteva, indicating that it is currently the more affordable of the two stocks.

In the previous week, Corteva had 4 more articles in the media than Nutrien. MarketBeat recorded 11 mentions for Corteva and 7 mentions for Nutrien. Nutrien's average media sentiment score of 0.82 beat Corteva's score of 0.31 indicating that Nutrien is being referred to more favorably in the news media.

Corteva pays an annual dividend of $0.72 per share and has a dividend yield of 0.9%. Nutrien pays an annual dividend of $2.20 per share and has a dividend yield of 3.1%. Corteva pays out 47.7% of its earnings in the form of a dividend. Nutrien pays out 44.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Corteva has increased its dividend for 5 consecutive years and Nutrien has increased its dividend for 7 consecutive years. Nutrien is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Nutrien has a net margin of 8.44% compared to Corteva's net margin of 5.66%. Corteva's return on equity of 10.18% beat Nutrien's return on equity.

81.5% of Corteva shares are owned by institutional investors. Comparatively, 63.1% of Nutrien shares are owned by institutional investors. 0.2% of Corteva shares are owned by company insiders. Comparatively, 3.1% of Nutrien shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Corteva has a beta of 0.57, suggesting that its stock price is 43% less volatile than the broader market. Comparatively, Nutrien has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market.

Corteva currently has a consensus price target of $91.90, suggesting a potential upside of 17.89%. Nutrien has a consensus price target of $81.15, suggesting a potential upside of 13.99%. Given Corteva's higher possible upside, equities research analysts clearly believe Corteva is more favorable than Nutrien.

Nutrien has a net margin of 8.44% compared to ICL Group's net margin of 3.95%. Nutrien's return on equity of 8.88% beat ICL Group's return on equity.

Nutrien has higher revenue and earnings than ICL Group. Nutrien is trading at a lower price-to-earnings ratio than ICL Group, indicating that it is currently the more affordable of the two stocks.

13.4% of ICL Group shares are owned by institutional investors. Comparatively, 63.1% of Nutrien shares are owned by institutional investors. 3.1% of Nutrien shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

ICL Group has a beta of 0.98, meaning that its stock price is 2% less volatile than the broader market. Comparatively, Nutrien has a beta of 0.62, meaning that its stock price is 38% less volatile than the broader market.

ICL Group pays an annual dividend of $0.17 per share and has a dividend yield of 3.3%. Nutrien pays an annual dividend of $2.20 per share and has a dividend yield of 3.1%. ICL Group pays out 70.8% of its earnings in the form of a dividend. Nutrien pays out 44.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nutrien has increased its dividend for 7 consecutive years.

ICL Group currently has a consensus target price of $6.00, suggesting a potential upside of 15.72%. Nutrien has a consensus target price of $81.15, suggesting a potential upside of 13.99%. Given ICL Group's higher possible upside, equities analysts plainly believe ICL Group is more favorable than Nutrien.

In the previous week, Nutrien had 3 more articles in the media than ICL Group. MarketBeat recorded 7 mentions for Nutrien and 4 mentions for ICL Group. Nutrien's average media sentiment score of 0.82 beat ICL Group's score of 0.11 indicating that Nutrien is being referred to more favorably in the news media.